I-cardiomyopathy ye-Hypertrophic (HCM) yenye yeemeko zengqondo ezinxulumene nokufa ngokukhawuleza kubadlali abancinci. Enyanisweni, i-HCM yenye yezinto ezixhaphakileyo zeengqondo zomzimba, ezichaphazela omnye kubantu abayi-500. EUnited States, i-HCM i-36% yecala lokufa ngokukhawuleza eliza kubadlali abancinci. Ngaphezu koko, ngaphezu kwesahlulo sokufa ngokukhawuleza okubangelwa yi-HCM kwenzeka kumaAfrika aseMerika.
Abantu abanakho i-HCM abavaliwe ukuvinjelwa kwimisebenzi yonke yezemidlalo, nangona banqatshelwe.
Nabani na ophethe i-HCM kufuneka azi malunga nomngcipheko wokufa ngokukhawuleza, kwaye kufuneka uqaphele ukuba iziphakamiso zengcali ziyavuma ukuba zilandelwe ngabantu abanalo mqathango.
Yintoni echanekileyo i-Hypertrophic Cardiomyopathy?
I-HCM yimeko yomzimba ebonakaliswa ngokunyaniseka okungaqhelekanga kwintliziyo yesisu, imeko ebizwa ngokuba yi-hypertrophy. I-hypertrophy inokubangela iingxaki ezininzi. Ivelisa "ukuqina" ngokweqile kwi-ventricle yekhohlo yentliziyo. Inokubangela ukuba kubekho umqobo wokukhawulela igazi kwi-ventricle engasekhohlo, ukuvelisa imeko efana ne- aortic stenosis . I-HCM idibaniswa nomsebenzi ongaqhelekanga we-valral valve .
Ezi mpawu ze-HCM zikhokelela ekusebenziseni i- diastolic ukungasebenzi kunye nokuhluleka kwentliziyo ye-diastolic , okanye ukunyanzelisa i-cardiomyopathy kunye nokunye "okuqhelekileyo" kweentliziyo ezingaphumeleli.
Inokubangela ukuba i- mitration ivuselelwe , yona leyo ingabangela okanye ibenze ingxaki yokulahleka kwentliziyo.
Kodwa isiphumo esisongelayo se-HCM kukuba sinokuyenza intliziyo ye-muscle ithambekele ekuphuhliseni i- tachycardia ye-ventricular kunye ne- fibrillation ye-ventricular, i- arrhythmias engabangela ukufa ngokukhawuleza. Nangona la ma-arrhythmias angenzeka naliphi na ixesha, ayenzeka kakhulu kunokwenzeka ngexesha lokuzivocavoca ngamandla.
Ngelishwa, ukufa ngokukhawuleza kungabonakaliswa okokuqala kweHCM, ingakumbi kubadlali abancinci. Ukujonga rhoqo nge- ECG , okanye ngcono, kodwa i-echocardiogram, yayiza kutyhila ingxaki kubadlali abaninzi ngaphambi kwesiganeko esisongela ubomi - kodwa ukuhlolwa kweso sihlandlo kuthathwa njengendleko engavumelekanga.
Nangona kunjalo, nawuphi na umdlali osemncinci oye wafa ilungu lentsapho ngokukhawuleza, okanye unobomi bentsapho yeHCM, kufuneka ahlolwe le meko. Kwaye ukuba i-HCM ifunyenwe, kufuneka ilandele iziphakamiso ezisebenzisiweyo zamatye atsha kunye neHCM.
Ziziphi iiNcomo zoQeqesho zoLutsha kwi-Athletics Young kunye neHCM?
Ngokomxholo we-36 we-Bethesda kwiNgqungquthela yokuQinisekisa kwiNgcaciso ye-Athletes ye-Competitive ne-Cardiovascular Impairmentities, abadlali abajongene ne-HCM akufanele bathathe inxaxheba kwimidlalo emincinci kakhulu, kunye neyona ndlela eyenzekayo kwimidlalo ephantsi (njenge-bowling okanye igolfu).
Labo abane-HCM abangabikho kwiqela elihlekileyo kodwa bahlanganyele kwimidlalo ngamaxesha ngamaxesha nako kufuneka baphephe imidlalo emininzi ephezulu njengebhokkey, basketball, kunye ne-tennis.
Olunye uhlobo lwezemidlalo olubandakanya ubunzima obunokulinganisela, kunye nemidlalo emininzi kakhulu, lunokuyithandwa ngokumodareyitha.
Ezi ziquka igalofu, i-tenisi ephindwe kabini, ukuloba nokukhwela.
Imithombo:
Maron, BJ, Ackerman, MJ, Nishimura, RA, et al. Umsebenzi we-4: I-HCM kunye nezinye i-Cardiomyopathies, i-Mitral Valve Prolapse, i-Myocarditis, ne-Marfan Syndrome. J Am Coll Cardiol 2005; 45: 1340.